LUMOSYR
Live / Applied — Non-final action mailed (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 21 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99454278
- Mark type
- Stylized text
- Filed
- 21 Oct 2025
- Attorney of record
- Palak Mayani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
Owner
- Merck Sharp & Dohme B.V., Haarlem, NL
Prosecution history
- 21 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — NON-FINAL ACTION WRITTEN
- 08 Jan 2026 — ASSIGNED TO EXAMINER
- 21 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Oct 2025 — NEW APPLICATION ENTERED